Unicycive Therapeutics Inc (UNCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,823 | -26,555 | -11,887 | -5,877 | 570 |
| Depreciation Amortization | 223 | 572 | 421 | 273 | 135 |
| Other Working Capital | 807 | -5,954 | -3,894 | -4,131 | -1,823 |
| Other Operating Activity | 5,552 | 620 | -7,925 | -7,588 | -7,785 |
| Operating Cash Flow | $-6,241 | $-31,317 | $-23,285 | $-17,323 | $-8,903 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -5,147 | -12,071 | N/A | N/A | 0 |
| PPE Investments | -8 | -24 | -24 | -22 | -16 |
| Investing Cash Flow | $-5,155 | $-12,095 | $-24 | $-22 | $-16 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | 0 | -212 | -212 | -211 | -160 |
| Common Stock Issued | N/A | 1,496 | 41,267 | 14,120 | N/A |
| Other Financing Activity | 19,569 | 45,184 | -1,193 | -379 | 2,706 |
| Financing Cash Flow | $19,569 | $46,468 | $39,862 | $13,530 | $2,546 |
| Beginning Cash Position | 29,198 | 26,142 | 26,142 | 26,142 | 26,142 |
| End Cash Position | 37,371 | 29,198 | 42,695 | 22,327 | 19,769 |
| Net Cash Flow | $8,173 | $3,056 | $16,553 | $-3,815 | $-6,373 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,241 | -31,317 | -23,285 | -17,323 | -8,903 |
| Capital Expenditure | -8 | -24 | -24 | -22 | -16 |
| Free Cash Flow | -6,249 | -31,341 | -23,309 | -17,345 | -8,919 |